Catalyst Biosciences Inc (NASDAQ:CBIO)
| 4.17 Delayed Data As of May 14 |  -0.12 / -2.80%Today’s Change | 4.05 Today|||52-Week Range 8.22 | -33.91% Year-to-Date |
| SECTOR Health Technology | INDUSTRY Biotechnology | MARKET CAP $131.0M |
Company Description
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on March 7, 1997 and is headquartered in South San Francisco, CA.
Contact Information
Catalyst Biosciences, Inc. 611 Gateway Boulevard South San Francisco California 94080 |
Employees
Shareholders
| Individual stakeholders | 6.32% |
| Other institutional | 46.20% |
| Mutual fund holders | 14.44% |
Top Executives
| Nassim Usman | President, Chief Executive Officer & Director |
| Clinton Musil | Chief Financial Officer |
| Howard Levy | Chief Medical Officer |
| Andrew Hetherington | Senior Vice President-Technical Operations |
| Linda Neuman | Vice President-Clinical Development |
